Aktuelle smitsomme sygdomme
Søgeord (rsv) valgt.
118 emner vises.
-
GSK Gets US FDA Approval for Expanded Use Of RSV VaccineMedscape Infectious DiseasesTilføjet 14. marts 2026
-
Weekly respiratory virus update, week 10, March 2026ECDC COVID-19 updatesTilføjet 14. marts 2026
-
RSV Hospitalization Burden Rises With Age and ComorbiditiesMedscape Infectious DiseasesTilføjet 13. marts 2026
-
Immunofitness: Vaccination for Healthy AgingMedscape Infectious DiseasesTilføjet 13. marts 2026
-
mRNA RSV Vaccine Safe in Transplant RecipientsMedscape Infectious DiseasesTilføjet 10. marts 2026
-
Outpatient RSV in Kids Younger Than 2 Has Distinct FeaturesMedscape Infectious DiseasesTilføjet 10. marts 2026
-
Two-season effectiveness of a single nirsevimab dose against RSV hospitalisation in healthy term-born infants: a population-based case–control study, Spain, October 2023 to March 2025Eurosurveillance latest updatesTilføjet 6. marts 2026
-
Subunit RSV Vaccine Recommended for Adults Older Than 75Medscape Infectious DiseasesTilføjet 4. marts 2026
-
Weekly respiratory virus update, week 8, February 2026ECDC COVID-19 updatesTilføjet 28. februar 2026
-
RSV Tamps Down Rhinovirus Coinfection in InfantsMedscape Infectious DiseasesTilføjet 26. februar 2026
-
Response to RSV Varies With AgeMedscape Infectious DiseasesTilføjet 25. februar 2026
-
RSV Hits Harder in Kids With AsthmaMedscape Infectious DiseasesTilføjet 24. februar 2026
-
Weekly respiratory virus update, week 7, February 2026ECDC COVID-19 updatesTilføjet 21. februar 2026
-
RSV Vaccine in Multidose Vial Matches Single-Dose VialMedscape Infectious DiseasesTilføjet 19. februar 2026
-
RSV Admission May Raise Risk for Cardiorespiratory EventsMedscape Infectious DiseasesTilføjet 17. februar 2026
-
Weekly respiratory virus update, week 6, January 2026ECDC COVID-19 updatesTilføjet 13. februar 2026
-
Vaccine Trials Advance Pneumovirus PreventionMedscape Infectious DiseasesTilføjet 12. februar 2026
-
Weekly respiratory virus update, week 5, January 2026ECDC COVID-19 updatesTilføjet 7. februar 2026
-
RSV Antibody Levels Tied to Posttransplant Infection RiskMedscape Infectious DiseasesTilføjet 6. februar 2026
-
More Older Adults to Get RSV Vaccine During AprilMedscape Infectious DiseasesTilføjet 5. februar 2026
-
Weekly respiratory virus update, week 4, January 2026ECDC COVID-19 updatesTilføjet 30. januar 2026
-
Weekly respiratory virus update, week 3, January 2026ECDC COVID-19 updatesTilføjet 24. januar 2026
-
Preterm Birth Raises Risk for Severe RSV, Even at 36 WeeksMedscape Infectious DiseasesTilføjet 24. januar 2026
-
Respiratory syncytial virus epidemiology and effectiveness of infant nirsevimab: 2024 results from the Australian Sentinel Hospital Network (FluCAN-PAEDS)Eurosurveillance latest updatesTilføjet 16. januar 2026
-
Weekly respiratory virus update, week 2, January 2026ECDC COVID-19 updatesTilføjet 16. januar 2026
-
Weekly respiratory virus update, week 1, January 2026ECDC COVID-19 updatesTilføjet 9. januar 2026
-
RSV Prevention Products Show Effectiveness in US InfantsMedscape Infectious DiseasesTilføjet 6. januar 2026
-
Nirsevimab May Top Maternal Shot for Infants' RSV PreventionMedscape Infectious DiseasesTilføjet 5. januar 2026
-
What’s the Latest on Anti-RSV Monoclonal Antibodies in 2025?Medscape Infectious DiseasesTilføjet 18. december 2025
-
RSV Infection May Carry Extended Cardiovascular RiskMedscape Infectious DiseasesTilføjet 15. december 2025
-
Weekly respiratory virus update, week 49, November 2025ECDC COVID-19 updatesTilføjet 12. december 2025
-
Exclusive-US FDA Launches Fresh Safety Scrutiny Of Approved RSV Therapies for InfantsMedscape Infectious DiseasesTilføjet 9. december 2025
-
Maternal RSV Shot Linked to Fewer Infant HospitalisationsMedscape Infectious DiseasesTilføjet 9. december 2025
-
Weekly respiratory virus update, week 48, November 2025ECDC COVID-19 updatesTilføjet 7. december 2025
-
RSV Vaccine Effectiveness May Decline in Older VeteransMedscape Infectious DiseasesTilføjet 2. december 2025
-
Weekly respiratory virus update, week 47, November 2025ECDC COVID-19 updatesTilføjet 29. november 2025
-
Nirsevimab Offers Early RSV Protection in European ChildrenMedscape Infectious DiseasesTilføjet 25. november 2025
-
How Long Can Nirsevimab Protect Against RSV?Medscape Infectious DiseasesTilføjet 25. november 2025
-
Weekly respiratory virus update, week 46, November 2025ECDC COVID-19 updatesTilføjet 22. november 2025
-
Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025Morbidity and Mortality Weekly Report (MMWR)Tilføjet 21. november 2025
-
Effectiveness of long-acting monoclonal antibodies against laboratory-confirmed RSV in children agedEurosurveillance latest updatesTilføjet 17. november 2025
-
Weekly respiratory virus update, week 45, November 2025ECDC COVID-19 updatesTilføjet 17. november 2025
-
RSV Vaccine Excels in Preventing Severe ARI in SeniorsMedscape Infectious DiseasesTilføjet 17. november 2025
-
Nirsevimab, Maternal Vaccine Show Effectiveness Against RSVMedscape Infectious DiseasesTilføjet 11. november 2025
-
Weekly respiratory virus update, week 44, November 2025ECDC COVID-19 updatesTilføjet 8. november 2025
-
Nirsevimab Sustains Protection Against RSV BronchiolitisMedscape Infectious DiseasesTilføjet 3. november 2025
-
Weekly respiratory virus update, week 43, October 2025ECDC COVID-19 updatesTilføjet 1. november 2025
-
Mythbusting: Protect yourself against the flu, RSV and COVID-19ECDC COVID-19 updatesTilføjet 22. oktober 2025
-
Weekly respiratory virus update, week 41, October 2025ECDC COVID-19 updatesTilføjet 17. oktober 2025
-
RSV Outcomes in SARD Patients Warrant Vaccine DiscussionsMedscape Infectious DiseasesTilføjet 17. oktober 2025